114 related articles for article (PubMed ID: 16895698)
1. [Tubular transporters OAT1 and MRP2 and clearance of adefovir].
Servais A; Lechat P; Zahr N; Urien S; Aymard G; Jaudon MC; Deray G; Isnard Bagnis C
Nephrol Ther; 2005 Nov; 1(5):296-300. PubMed ID: 16895698
[TBL] [Abstract][Full Text] [Related]
2. Tubular transporters and clearance of adefovir.
Servais A; Lechat P; Zahr N; Urien S; Aymard G; Jaudon MC; Deray G; Isnard Bagnis C
Eur J Pharmacol; 2006 Jul; 540(1-3):168-74. PubMed ID: 16756973
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans.
Maeda K; Tian Y; Fujita T; Ikeda Y; Kumagai Y; Kondo T; Tanabe K; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
Eur J Pharm Sci; 2014 Aug; 59():94-103. PubMed ID: 24747579
[TBL] [Abstract][Full Text] [Related]
4. Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir.
Imaoka T; Kusuhara H; Adachi M; Schuetz JD; Takeuchi K; Sugiyama Y
Mol Pharmacol; 2007 Feb; 71(2):619-27. PubMed ID: 17110501
[TBL] [Abstract][Full Text] [Related]
5. Uricosuric Agents Affect Plasma and Kidney Concentration of Adefovir via Inhibition of Oat1 and Mrp2 in Rats.
Motoki K; Taniguchi T; Ashizawa N; Sakai M; Chikamatsu N; Yamano K; Iwanaga T
Biol Pharm Bull; 2023; 46(2):170-176. PubMed ID: 36724945
[TBL] [Abstract][Full Text] [Related]
6. Nucleoside phosphonate interactions with multiple organic anion transporters in renal proximal tubule.
Miller DS
J Pharmacol Exp Ther; 2001 Nov; 299(2):567-74. PubMed ID: 11602668
[TBL] [Abstract][Full Text] [Related]
7. Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6).
Wong CC; Botting NP; Orfila C; Al-Maharik N; Williamson G
Biochem Pharmacol; 2011 Apr; 81(7):942-9. PubMed ID: 21244849
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.
Cundy KC
Clin Pharmacokinet; 1999 Feb; 36(2):127-43. PubMed ID: 10092959
[TBL] [Abstract][Full Text] [Related]
9. Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1/3 and MRP2.
Liao XY; Deng QQ; Han L; Wu ZT; Peng ZL; Xie Y; Wang GJ; Aa JY; Pan GY
Acta Pharmacol Sin; 2020 Jan; 41(1):129-137. PubMed ID: 31341258
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance-associated protein 2 (MRP2) affects hepatobiliary elimination but not the intestinal disposition of tenofovir disoproxil fumarate and its metabolites.
Mallants R; Van Oosterwyck K; Van Vaeck L; Mols R; De Clercq E; Augustijns P
Xenobiotica; 2005; 35(10-11):1055-66. PubMed ID: 16393861
[TBL] [Abstract][Full Text] [Related]
11. Systemic and renal pharmacokinetics of adefovir and tenofovir upon coadministration.
Kearney BP; Ramanathan S; Cheng AK; Ebrahimi R; Shah J
J Clin Pharmacol; 2005 Aug; 45(8):935-40. PubMed ID: 16027404
[TBL] [Abstract][Full Text] [Related]
12. Adefovir accumulation and nephrotoxicity in renal interstitium: Role of organic anion transporters of kidney.
Zhou Y; Yang Y; Wang P; Wei M; Ma Y; Wu X
Life Sci; 2019 May; 224():41-50. PubMed ID: 30902543
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1.
Mulato AS; Ho ES; Cihlar T
J Pharmacol Exp Ther; 2000 Oct; 295(1):10-5. PubMed ID: 10991954
[TBL] [Abstract][Full Text] [Related]
14. Organic anion transporters involved in the excretion of bestatin in the kidney.
Zhu Y; Meng Q; Wang C; Liu Q; Sun H; Kaku T; Liu K
Peptides; 2012 Feb; 33(2):265-71. PubMed ID: 22273603
[TBL] [Abstract][Full Text] [Related]
15. Developmental expression of renal organic anion transporters in rat kidney and its effect on renal secretion of phenolsulfonphthalein.
Nomura M; Motohashi H; Sekine H; Katsura T; Inui K
Am J Physiol Renal Physiol; 2012 Jun; 302(12):F1640-9. PubMed ID: 22419695
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of pradefovir and PMEA in healthy volunteers after oral dosing of pradefovir.
Lin CC; Xu C; Teng A; Yeh LT; Peterson J
J Clin Pharmacol; 2005 Nov; 45(11):1250-8. PubMed ID: 16239358
[TBL] [Abstract][Full Text] [Related]
17. Apigenin, a novel candidate involving herb-drug interaction (HDI), interacts with organic anion transporter 1 (OAT1).
Wu T; Li H; Chen J; Cao Y; Fu W; Zhou P; Pang J
Pharmacol Rep; 2017 Dec; 69(6):1254-1262. PubMed ID: 29128807
[TBL] [Abstract][Full Text] [Related]
18. Low-dose probenecid selectively inhibits urinary excretion of phenolsulfonphthalein in rats without affecting biliary excretion.
Shin YJ; Lee JH; Oh JH; Lee YJ
J Appl Toxicol; 2013 Jun; 33(6):511-5. PubMed ID: 22161506
[TBL] [Abstract][Full Text] [Related]
19. Organic anion transporter OAT1 is involved in renal handling of citrulline.
Nakakariya M; Shima Y; Shirasaka Y; Mitsuoka K; Nakanishi T; Tamai I
Am J Physiol Renal Physiol; 2009 Jul; 297(1):F71-9. PubMed ID: 19403644
[TBL] [Abstract][Full Text] [Related]
20. Role of basolateral efflux transporter MRP4 in the intestinal absorption of the antiviral drug adefovir dipivoxil.
Ming X; Thakker DR
Biochem Pharmacol; 2010 Feb; 79(3):455-62. PubMed ID: 19735648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
